Approval from British regulators for the $69 billion takeover was the last hurdle left for the tech giant, which saw off serious challenges to the transaction.
Category: Federal Trade Commission
-
Musk, V.P. Harris, Dimon to Speak at the 2023 DealBook Summit
The conference on Nov. 29 will bring together the biggest newsmakers in business, politics and culture.
-
What Is a ‘Moat’?
Company leaders talk a lot about “moats.” That can sometimes invite regulatory scrutiny, as it did with Amazon, which was sued this week.
-
Lina Khan Finally Takes On Amazon Over Its Market Power
The F.T.C. chair, who published an influential law school paper on the e-commerce giant, is now fighting the company over its market dominance.
-
Lina Khan vs. Jeff Bezos: This Is Big Tech’s Real Cage Match
The chair of the Federal Trade Commission wants to disrupt Amazon, whose founder built a trillion-dollar firm by disrupting retail.
-
For Amazon’s Andy Jassy, a Cleanup Job Just Got a Lot Bigger
The F.T.C. accused the internet giant of protecting an online retail monopoly and forcing higher prices onto consumers.
-
U.S. Accuses Amazon of Illegally Protecting Monopoly in Online Retail
The Federal Trade Commission and 17 states filed a lawsuit against Amazon for “illegal conduct” in its online store and services to merchants, which stifled competition.
-
You’ve Got (Scam) Mail
Is everyone being swindled all the time and just not talking about it?
-
FTC Sues Anesthesia Group Backed by Private Equity, Claiming Antitrust
The federal agency claims the company’s practices amount to antitrust activity, a new salvo in the government’s scrutiny of health care consolidation that has led to higher prices.
-
FTC Sues Anesthesia Group Backed by Private Equity, Claiming Antitrust
The federal agency claims the company’s practices amount to antitrust activity, a new salvo in the government’s scrutiny of health care consolidation that has led to higher prices.
-
How to Claim Your Fortnite Refund
Epic Games, the maker of Fortnite, agreed to pay $245 million to refund customers over accusations that it tricked players into making unwanted purchases.
-
Common Patenting Tactic by Drug Companies May Be Illegal, F.T.C. Says
Experts say the exploitation of a loophole in the patent system has contributed to high prices for inhalers.